Tyme Technologies Inc. (TYME)

[mcsharkey]

Thanks again Axel, with the Scientific American story followed by this celebrity's personal testament to SM-88, we got our relations firm pushing the CLINICAL TRIAL reporting envelope.

We know the Scientific American article funded, maybe written by TYME personnel listed within the BANNER statement, and LINK TO FULL ARTICLE

A Trickster Enters the Fight Against Metastatic Cancers

This article was produced for TYME by Scientific American Custom Media, a division separate from the magazine's board of editors.

This technical data from that blows me away, and TYME would be criminally libel (IMHO) if they just made this up......
SM-88 was specifically designed to target the cancer cell and spare the patient’s healthy cells. To date, that has been proven in clinical trials. SM-88 has demonstrated confirmed responses in patients across 15 different tumor types with only two out of approximately 180 patients having serious adverse events, possibly or probably, related to SM-88. For perspective, the most commonly used pancreatic cancer regimens have more than 50% of patients experiencing drug related serious adverse evenI'm thinking this is great for all of us.

You don't do lawns in Florida by any chance:)?

GLTUA